Iraq’s Balancing Arithmetic in the US-Iran War 
International Pollution by Chinese Miners Worsens 
ASEAN: Strategic Center of Gravity in US–China Rivalry 
When Scottish doctor Alexander Fleming accidentally discovered the first antibiotic in 1928, he changed the course of history, extending global life expectancy by decades and saving millions of lives on the battlefield and beyond.
But humanity’s dependence on his discovery has fuelled a modern crisis: antimicrobial resistance, or AMR.
Decades of overuse and misuse of the drug have allowed “superbugs” – bacteria that have mutated to survive antibiotic treatments – to evolve.
Advertisement
According to a 2014 UK study, AMR infections may kill 10 million people annually by 2050, surpassing cancer as a leading cause of death if no intervention is taken.
To address this problem, scientists at the University of Hong Kong (HKU) have developed a skincare product for eczema that aims to control bacterial infections without killing them.
Advertisement
Eczema is a condition affecting 800 million people, or 10 per cent of the world’s population.
Don't Miss:
-
US Congress explores new tariffs, sanctions to counter China’s shipbuilding dominance
-
What is Beijing thinking? Why Washington is struggling to understand its rival
-
Chile hunts for copper buyers beyond China with US$100 billion mining plan
-
US not getting enough critical minerals from China, Greer says as Xi-Trump meeting looms
-
How China and Indonesia can build a truly sturdy partnership